Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We are analyzing https://www.nature.com/articles/6695007.

Title:
Molecular cytogenetic analysis of 11 new breast cancer cell lines | British Journal of Cancer
Description:
We describe a survey of genetic changes by comparative genomic hybridization (CGH) in 11 human breast cancer cell lines recently established in our laboratory. The most common gains took place at 8q (73%), 1q (64%), 7q (64%), 3q (45%) and 7p (45%), whereas losses were most frequent at Xp (54%), 8p (45%), 18q (45%) and Xq (45%). Many of the cell lines displayed prominent, localized DNA amplifications by CGH. One-third of these loci affected breast cancer oncogenes, whose amplifications were validated with specific probes: 17q12 (two cell lines with ERBB2 amplifications), 11q13 (two with cyclin-D1), 8p11–p12 (two with FGFR1) and 10q25 (one with FGFR2). Gains and amplifications affecting 8q were the most common genetic alterations in these cell lines with the minimal, common region of involvement at 8q22–q23. No high-level MYC (at 8q24) amplifications were found in any of the cell lines. Two-thirds of the amplification sites took place at loci not associated with established oncogenes, such as 1q41–q43, 7q21–q22, 7q31, 8q23, 9p21–p23, 11p12–p14, 15q12–q14, 16q13–q21, 17q23, 20p11–p12 and 20q13. Several of these locations have not been previously reported and may harbour important genes whose amplification is selected for during cancer development. In summary, this set of breast cancer cell lines displaying prominent DNA amplifications should facilitate discovery and functional analysis of genes and signal transduction pathways contributing to breast cancer development.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$63,100 per month
According to our algorithms, Nature.com's monthly online income from display advertising ranges from $42,042 to $115,616.

Keywords {🔍}

cancer, breast, article, google, scholar, cas, kallioniemi, human, cell, nature, ethier, lines, res, pubmed, amplification, growth, cells, content, genes, amplified, tanner, cookies, molecular, amplifications, privacy, analysis, open, comparative, genomic, hybridization, cgh, development, isola, karhu, gene, research, data, journal, access, forozan, ammerman, genetic, dna, carcinoma, usa, treat, press, tirkkonen, factor, advertising,

Topics {✒️}

nature portfolio privacy policy nature med 4 nature advertising 0/ reprints breast cancer development high-throughput molecular profiling c-erbb-2 gene amplification social media selective media sum-159pt cells personal data human breast cancer molecular cytogenetics breast cancer cells breast carcinoma cells molecular cytogenetic analysis primary breast cancer data protection cancer development human breast cancers permissions breast cancer based drosophila aurora kinase functional analysis human colorectal cancers dna sequence amplification privacy localized dna amplifications chromosomal gains cancer biology cell lines explore content similar content epidermal growth factor hormone receptor positive comparative genomic hybridization amplified dna sequences journals search log high-level myc tyrosine phosphorylated erbb-2 european economic area metstatic lymph node progressively elevated levels michigan medical school predicts poor outcome comparative transcriptional analyses amplification-related gain breast cancer

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Molecular cytogenetic analysis of 11 new breast cancer cell lines
         description:We describe a survey of genetic changes by comparative genomic hybridization (CGH) in 11 human breast cancer cell lines recently established in our laboratory. The most common gains took place at 8q (73%), 1q (64%), 7q (64%), 3q (45%) and 7p (45%), whereas losses were most frequent at Xp (54%), 8p (45%), 18q (45%) and Xq (45%). Many of the cell lines displayed prominent, localized DNA amplifications by CGH. One-third of these loci affected breast cancer oncogenes, whose amplifications were validated with specific probes: 17q12 (two cell lines with ERBB2 amplifications), 11q13 (two with cyclin-D1), 8p11–p12 (two with FGFR1) and 10q25 (one with FGFR2). Gains and amplifications affecting 8q were the most common genetic alterations in these cell lines with the minimal, common region of involvement at 8q22–q23. No high-level MYC (at 8q24) amplifications were found in any of the cell lines. Two-thirds of the amplification sites took place at loci not associated with established oncogenes, such as 1q41–q43, 7q21–q22, 7q31, 8q23, 9p21–p23, 11p12–p14, 15q12–q14, 16q13–q21, 17q23, 20p11–p12 and 20q13. Several of these locations have not been previously reported and may harbour important genes whose amplification is selected for during cancer development. In summary, this set of breast cancer cell lines displaying prominent DNA amplifications should facilitate discovery and functional analysis of genes and signal transduction pathways contributing to breast cancer development.
         datePublished:1999-11-26T00:00:00Z
         dateModified:2011-11-16T00:00:00Z
         pageStart:1328
         pageEnd:1334
         sameAs:https://doi.org/10.1038/sj.bjc.6695007
         keywords:
            molecular cytogenetics
            FISH
            CGH
            chromosomal aberrations
            oncogene amplification
            Biomedicine
            general
            Cancer Research
            Epidemiology
            Molecular Medicine
            Oncology
            Drug Resistance
         image:
         isPartOf:
            name:British Journal of Cancer
            issn:
               1532-1827
               0007-0920
            volumeNumber:81
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:F Forozan
               affiliation:
                     name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
                     address:
                        name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:R Veldman
               affiliation:
                     name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
                     address:
                        name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:C A Ammerman
               affiliation:
                     name:University of Michigan Medical School, 7312 Cancer Center, 1500 E. Medical Center Dr
                     address:
                        name:Department of Radiation Oncology, Division of Radiation and Cancer Biology, University of Michigan Medical School, 7312 Cancer Center, 1500 E. Medical Center Dr, Ann Arbor, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:N Z Parsa
               affiliation:
                     name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
                     address:
                        name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:A Kallioniemi
               affiliation:
                     name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
                     address:
                        name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:O-P Kallioniemi
               affiliation:
                     name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
                     address:
                        name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S P Ethier
               affiliation:
                     name:University of Michigan Medical School, 7312 Cancer Center, 1500 E. Medical Center Dr
                     address:
                        name:Department of Radiation Oncology, Division of Radiation and Cancer Biology, University of Michigan Medical School, 7312 Cancer Center, 1500 E. Medical Center Dr, Ann Arbor, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Molecular cytogenetic analysis of 11 new breast cancer cell lines
      description:We describe a survey of genetic changes by comparative genomic hybridization (CGH) in 11 human breast cancer cell lines recently established in our laboratory. The most common gains took place at 8q (73%), 1q (64%), 7q (64%), 3q (45%) and 7p (45%), whereas losses were most frequent at Xp (54%), 8p (45%), 18q (45%) and Xq (45%). Many of the cell lines displayed prominent, localized DNA amplifications by CGH. One-third of these loci affected breast cancer oncogenes, whose amplifications were validated with specific probes: 17q12 (two cell lines with ERBB2 amplifications), 11q13 (two with cyclin-D1), 8p11–p12 (two with FGFR1) and 10q25 (one with FGFR2). Gains and amplifications affecting 8q were the most common genetic alterations in these cell lines with the minimal, common region of involvement at 8q22–q23. No high-level MYC (at 8q24) amplifications were found in any of the cell lines. Two-thirds of the amplification sites took place at loci not associated with established oncogenes, such as 1q41–q43, 7q21–q22, 7q31, 8q23, 9p21–p23, 11p12–p14, 15q12–q14, 16q13–q21, 17q23, 20p11–p12 and 20q13. Several of these locations have not been previously reported and may harbour important genes whose amplification is selected for during cancer development. In summary, this set of breast cancer cell lines displaying prominent DNA amplifications should facilitate discovery and functional analysis of genes and signal transduction pathways contributing to breast cancer development.
      datePublished:1999-11-26T00:00:00Z
      dateModified:2011-11-16T00:00:00Z
      pageStart:1328
      pageEnd:1334
      sameAs:https://doi.org/10.1038/sj.bjc.6695007
      keywords:
         molecular cytogenetics
         FISH
         CGH
         chromosomal aberrations
         oncogene amplification
         Biomedicine
         general
         Cancer Research
         Epidemiology
         Molecular Medicine
         Oncology
         Drug Resistance
      image:
      isPartOf:
         name:British Journal of Cancer
         issn:
            1532-1827
            0007-0920
         volumeNumber:81
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:F Forozan
            affiliation:
                  name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
                  address:
                     name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:R Veldman
            affiliation:
                  name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
                  address:
                     name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:C A Ammerman
            affiliation:
                  name:University of Michigan Medical School, 7312 Cancer Center, 1500 E. Medical Center Dr
                  address:
                     name:Department of Radiation Oncology, Division of Radiation and Cancer Biology, University of Michigan Medical School, 7312 Cancer Center, 1500 E. Medical Center Dr, Ann Arbor, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:N Z Parsa
            affiliation:
                  name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
                  address:
                     name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:A Kallioniemi
            affiliation:
                  name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
                  address:
                     name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:O-P Kallioniemi
            affiliation:
                  name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
                  address:
                     name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S P Ethier
            affiliation:
                  name:University of Michigan Medical School, 7312 Cancer Center, 1500 E. Medical Center Dr
                  address:
                     name:Department of Radiation Oncology, Division of Radiation and Cancer Biology, University of Michigan Medical School, 7312 Cancer Center, 1500 E. Medical Center Dr, Ann Arbor, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:British Journal of Cancer
      issn:
         1532-1827
         0007-0920
      volumeNumber:81
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
      address:
         name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
         type:PostalAddress
      name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
      address:
         name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
         type:PostalAddress
      name:University of Michigan Medical School, 7312 Cancer Center, 1500 E. Medical Center Dr
      address:
         name:Department of Radiation Oncology, Division of Radiation and Cancer Biology, University of Michigan Medical School, 7312 Cancer Center, 1500 E. Medical Center Dr, Ann Arbor, USA
         type:PostalAddress
      name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
      address:
         name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
         type:PostalAddress
      name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
      address:
         name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
         type:PostalAddress
      name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
      address:
         name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
         type:PostalAddress
      name:University of Michigan Medical School, 7312 Cancer Center, 1500 E. Medical Center Dr
      address:
         name:Department of Radiation Oncology, Division of Radiation and Cancer Biology, University of Michigan Medical School, 7312 Cancer Center, 1500 E. Medical Center Dr, Ann Arbor, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:F Forozan
      affiliation:
            name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
            address:
               name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
               type:PostalAddress
            type:Organization
      name:R Veldman
      affiliation:
            name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
            address:
               name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
               type:PostalAddress
            type:Organization
      name:C A Ammerman
      affiliation:
            name:University of Michigan Medical School, 7312 Cancer Center, 1500 E. Medical Center Dr
            address:
               name:Department of Radiation Oncology, Division of Radiation and Cancer Biology, University of Michigan Medical School, 7312 Cancer Center, 1500 E. Medical Center Dr, Ann Arbor, USA
               type:PostalAddress
            type:Organization
      name:N Z Parsa
      affiliation:
            name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
            address:
               name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
               type:PostalAddress
            type:Organization
      name:A Kallioniemi
      affiliation:
            name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
            address:
               name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
               type:PostalAddress
            type:Organization
      name:O-P Kallioniemi
      affiliation:
            name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health
            address:
               name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
               type:PostalAddress
            type:Organization
      name:S P Ethier
      affiliation:
            name:University of Michigan Medical School, 7312 Cancer Center, 1500 E. Medical Center Dr
            address:
               name:Department of Radiation Oncology, Division of Radiation and Cancer Biology, University of Michigan Medical School, 7312 Cancer Center, 1500 E. Medical Center Dr, Ann Arbor, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
      name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
      name:Department of Radiation Oncology, Division of Radiation and Cancer Biology, University of Michigan Medical School, 7312 Cancer Center, 1500 E. Medical Center Dr, Ann Arbor, USA
      name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
      name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
      name:Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA
      name:Department of Radiation Oncology, Division of Radiation and Cancer Biology, University of Michigan Medical School, 7312 Cancer Center, 1500 E. Medical Center Dr, Ann Arbor, USA

Social Networks {👍}(1)

External Links {🔗}(81)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {📦}

  • Crossref

4.58s.